Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Pemigatinib (Proposed Inn)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 21Incyte Corporation

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    PEMIGATINIB

    Brand Name : PEMAZYRE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 4.5MG

    Packaging :

    Approval Date : 2020-04-17

    Application Number : 213736

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    PEMIGATINIB

    Brand Name : PEMAZYRE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 9MG

    Packaging :

    Approval Date : 2020-04-17

    Application Number : 213736

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    PEMIGATINIB

    Brand Name : PEMAZYRE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 13.5MG

    Packaging :

    Approval Date : 2020-04-17

    Application Number : 213736

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 13.5mg

    Packaging :

    Approval Date : 26/03/2021

    Application Number : 20191122000062

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 4.5mg

    Packaging :

    Approval Date : 26/03/2021

    Application Number : 20191122000048

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength :

    Packaging :

    Approval Date : 26/03/2021

    Application Number : 20191122000055

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Limited-Term

    Registration Country : Switzerland

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 4.5mg

    Packaging :

    Approval Date : 13/07/2021

    Application Number : 68143

    Regulatory Info : Limited-Term

    Registration Country : Switzerland

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Limited-Term

    Registration Country : Switzerland

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 9mg

    Packaging :

    Approval Date : 13/07/2021

    Application Number : 68143

    Regulatory Info : Limited-Term

    Registration Country : Switzerland

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Limited-Term

    Registration Country : Switzerland

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 13.5mg

    Packaging :

    Approval Date : 13/07/2021

    Application Number : 68143

    Regulatory Info : Limited-Term

    Registration Country : Switzerland

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Marketed

    Registration Country : Norway

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 13.5mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Marketed

    Registration Country : Norway

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Marketed

    Registration Country : Norway

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 4.5mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Marketed

    Registration Country : Norway

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Marketed

    Registration Country : Norway

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength :

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Marketed

    Registration Country : Norway

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Estonia

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 135mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Prescription

    Registration Country : Estonia

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Estonia

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 45mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Prescription

    Registration Country : Estonia

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Estonia

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 9mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Prescription

    Registration Country : Estonia

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Authorized

    Registration Country : Spain

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 13.5MG

    Packaging :

    Approval Date : 10-05-2021

    Application Number : 1211535005

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Authorized

    Registration Country : Spain

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 4.5MG

    Packaging :

    Approval Date : 07-05-2021

    Application Number : 1211535001

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Authorized

    Registration Country : Spain

    Pemigatinib

    Brand Name : Pemazyre

    Dosage Form : Tablet

    Dosage Strength : 9MG

    Packaging :

    Approval Date : 07-05-2021

    Application Number : 1211535003

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    PEMIGATINIB

    Brand Name : PEMAZYRE

    Dosage Form : TABLET

    Dosage Strength : 4.5MG

    Packaging :

    Approval Date :

    Application Number : 2519933

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    Incyte Corporation

    U.S.A
    IPPE
    Not Confirmed
    arrow

    Incyte Corporation

    U.S.A
    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    PEMIGATINIB

    Brand Name : PEMAZYRE

    Dosage Form : TABLET

    Dosage Strength : 9MG

    Packaging :

    Approval Date :

    Application Number : 2519941

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.